Australia Medical Devices & Instruments Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Medical Devices & Instruments
Impedimed Ltd (ASX:IPD) Q2 2024 Earnings Call Transcript Highlights: Key Takeaways and Financial Performance
Discover the critical insights from Impedimed Ltd's latest earnings call, including revenue trends, market opportunities, and strategic initiatives. Sep 14, 2024
Medical Devices & Instruments
Impedimed Ltd (ASX:IPD) Q4 2024 Earnings Call Transcript Highlights: Strong Core Business Growth Amid Global Revenue Decline
Impedimed Ltd (ASX:IPD) reports a 14% increase in core business revenue and an 18% rise in patient tests, despite a 9% drop in global revenue. Sep 14, 2024
Medical Devices & Instruments
Atomo Diagnostics Ltd (ASX:AT1) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Improved Margins
Atomo Diagnostics Ltd (ASX:AT1) reports a 41% increase in total revenue and significant improvements in gross margins and EBITDA loss reduction. Sep 14, 2024